Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -28.07% is 22% above its 5-year average of -36.05%, around the middle of its 5-year range (-68.63%–-10.11%).
18.40% above its 12-month average of -34.40%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -10.28%.
RETURN ON ASSETS (ROA)
-28.07%
RETURN ON ASSETS (ROA) AVG TTM
-34.40%
RETURN ON ASSETS (ROA) AVG 3Y
-29.52%
RETURN ON ASSETS (ROA) AVG 5Y
-36.05%
RETURN ON ASSETS (ROA) AVG 10Y
-32.01%
RETURN ON ASSETS (ROA) AVG 15Y
-29.28%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.40%
CURRENT VS 3Y AVG
+4.93%
CURRENT VS 5Y AVG
+22.15%
CURRENT VS 10Y AVG
+12.32%
CURRENT VS 15Y AVG
+4.14%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+13.00%
vs the sector median at left
MediWound Ltd.
Market Cap
$168.92M
Return on Assets (ROA)
-28.07%
TTM Avg
-34.40%
3Y Avg
-29.52%
5Y Avg
-36.05%
Market Cap
$169.53M
Return on Assets (ROA)
-6.21%
TTM Avg
-15.18%
3Y Avg
-15.88%
5Y Avg
-16.43%
Market Cap
$168.10M
Return on Assets (ROA)
-534.43%
TTM Avg
-94.69%
3Y Avg
-82.47%
5Y Avg
-71.30%
Market Cap
$171.13M
Return on Assets (ROA)
-41.88%
TTM Avg
-12.18%
3Y Avg
-27.40%
5Y Avg
-32.78%
Market Cap
$172.42M
Return on Assets (ROA)
-22.20%
TTM Avg
3.18%
3Y Avg
2.72%
5Y Avg
6.35%
Market Cap
$165.32M
Return on Assets (ROA)
2.80%
TTM Avg
-4.42%
3Y Avg
-6.73%
5Y Avg
-5.05%
Market Cap
$165.27M
Return on Assets (ROA)
-34.75%
TTM Avg
-23.73%
3Y Avg
-25.63%
5Y Avg
-26.84%
Market Cap
$173.76M
Return on Assets (ROA)
-32.29%
TTM Avg
-23.28%
3Y Avg
-25.06%
5Y Avg
-27.38%
Market Cap
$174.27M
Return on Assets (ROA)
-79.26%
TTM Avg
-73.67%
3Y Avg
-58.36%
5Y Avg
-102.57%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediWound Ltd. (MDWD) | $168.92M | -28.07% | -34.40% | -29.52% | -36.05% |
| Journey Medical Corporation (DERM)vs › | $169.53M | -6.21% | -15.18% | -15.88% | -16.43% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | -534.43% | -94.69% | -82.47% | -71.30% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -41.88% | -12.18% | -27.40% | -32.78% |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | -22.20% | 3.18% | 2.72% | 6.35% |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 2.80% | -4.42% | -6.73% | -5.05% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | -34.75% | -23.73% | -25.63% | -26.84% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -32.29% | -23.28% | -25.06% | -27.38% |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | -79.26% | -73.67% | -58.36% | -102.57% |
| Quanterix Corporation (QTRX)vs › | $162.04M | -38.52% | -17.54% | -16.16% | -14.54% |
ROA
-28.1%
ROE
-56.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -27.68% |
| 2024-12-31 | -41.12% |
| 2023-12-31 | -10.11% |
| 2022-12-31 | -39.19% |
| 2021-12-31 | -68.63% |
| 2020-12-31 | -29.60% |
| 2019-12-31 | 12.21% |
| 2018-12-31 | -3.00% |
| 2017-12-31 | -50.18% |
| 2016-12-31 | -52.80% |
| 2015-12-31 | -42.05% |
| 2014-12-31 | -26.54% |
| 2013-12-31 | -103.54% |
| 2012-12-31 | 43.01% |
| 2011-12-31 | 0.00% |
